One of the most common questions we receive at PerformanceLabs UK is about the legal framework surrounding research compounds in the UK. This article breaks down the key legislation, the role of the MHRA, and what it means to operate — and purchase — within the law.
There are two primary pieces of legislation relevant to research compounds in the UK:
The Misuse of Drugs Act 1971 classifies specific substances as controlled drugs, divided into Class A, B, and C. The majority of research peptides currently in circulation are not listed under this act and are therefore not classified as controlled substances. However, this can change — schedules are reviewed and updated, and researchers should always verify the current status of any compound before sourcing.
The Human Medicines Regulations 2012 is the more directly relevant legislation for research compound suppliers. This regulation governs the marketing, supply, and sale of medicines in the UK. Under this framework, it is illegal to sell any compound for human consumption without MHRA authorisation. This is the legislation that defines the legal boundary between a research compound and an unlicensed medicine.
The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK government body responsible for ensuring that medicines and medical devices work and are acceptably safe. Its role is comparable to that of the FDA in the United States.
For research compounds, the MHRA's position is clear: compounds may be legally sold and purchased for research and laboratory purposes, provided they are not marketed or presented as having therapeutic value for human use. The moment a supplier makes health claims, suggests human administration, or markets a compound as a treatment or supplement, that compound is being presented as a medicine — and without MHRA authorisation, that is a regulatory violation.
The "research use only" classification is not a legal loophole or a disclaimer that can be applied superficially to any product. It reflects a genuine and legally meaningful category of compound use — laboratory and scientific research, conducted under appropriate conditions, for the purpose of scientific investigation.
For a supplier to operate legitimately within this framework:
If you are sourcing research compounds in the UK, you are responsible for ensuring your use aligns with the research-only framework. Purchasing a compound labelled for research use, and then using it outside of a research context, does not transfer legal responsibility to the supplier — it creates personal legal exposure for the purchaser.
PerformanceLabs UK operates strictly within the MHRA research compounds framework. We do not supply compounds to individuals seeking them for personal use, self-administration, or therapeutic purposes. All purchasers confirm upon ordering that compounds are being acquired solely for research use.
The regulatory landscape for research compounds is not static. We recommend checking the MHRA website and the Home Office controlled drugs list regularly if you are active in this space. When in doubt, seek independent legal counsel.
This website supplies research reference materials for in vitro laboratory use only. By entering, you confirm you are 18 years of age or older and accessing this site for legitimate research purposes.